TEVA.TA - Teva Pharmaceutical Industries Limited

Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
6,540.00
+150.00 (+2.35%)
At close: 5:24PM IST
Stock chart is not supported by your current browser
Previous Close6,390.00
Open6,403.00
Bid6,540.00 x 200
Ask6,544.00 x 34100
Day's Range6,372.00 - 6,740.00
52 Week Range38.20 - 6,740.00
Volume2,330,498
Avg. Volume1,269,208
Market Cap66.446B
Beta-0.58
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.36 (7.11%)
Ex-Dividend Date2017-03-02
1y Target EstN/A
  • Billionaire George Soros Is Betting Big Against These 2 Pharma Stocks
    Motley Fool4 hours ago

    Billionaire George Soros Is Betting Big Against These 2 Pharma Stocks

    Can Valeant and Teva rebound? George Soros' namesake fund doesn't seem to think so.

  • Reuters9 hours ago

    Union says workers at Israeli drugs firm Teva to strike on Tuesday

    A union ordered a strike by workers at Israeli drugsmaker Teva Pharmaceutical Industries (TEVA.TA) on Tuesday after two days of protests by employees over planned job cuts by the indebted firm. Hundreds of Teva (TEVA.N) employees, many wearing white lab coats, blocked the road and entrance to the Finance Ministry in Jerusalem, where union leaders met ministry officials and Teva representatives. After that meeting, Avi Nissenkorn, head of Histadrut, an umbrella organization representing public sector unions and also workers at some private firms such as Teva, ordered a suspension of activity at all Teva sites in Israel on Tuesday.

  • Reuters10 hours ago

    Union says workers at Israeli drugs firm Teva to strike on Tuesday

    A union ordered a strike by workers at Israeli drugsmaker Teva Pharmaceutical Industries on Tuesday after two days of protests by employees over planned job cuts by the indebted firm. Hundreds of Teva employees, many wearing white lab coats, blocked the road and entrance to the Finance Ministry in Jerusalem, where union leaders met ministry officials and Teva representatives. After that meeting, Avi Nissenkorn, head of Histadrut, an umbrella organisation representing public sector unions and also workers at some private firms such as Teva, ordered a suspension of activity at all Teva sites in Israel on Tuesday.

  • 24/7 Wall St.11 hours ago

    FDA Accepts Teva Pharma’s BLA For Migraine Drug

    Teva Pharmaceutical Industries kicked off the week by announced an FDA for its treatment for migraines.

  • MarketWatch11 hours ago

    Teva’s new plan is to raise drug prices, but it won’t be easy

    Generic drug prices have been declining all year, posing a crisis for the industry and prompting the very cost-cutting that Teva just announced.

  • Israel Not Aiming to Punish Teva on Job Cuts, Official Says
    Bloomberg13 hours ago

    Israel Not Aiming to Punish Teva on Job Cuts, Official Says

    The Israeli government isn’t considering punitive measures against debt-strapped Teva Pharmaceutical Industries Ltd. over its plan to fire a quarter of its Israeli work force, according to an official ...

  • Reuters13 hours ago

    Teva Pharm woes seen denting Israeli exports, economic growth

    Israel's export-dependent economy is expected to take a hit from planned job cuts and plant closures at its largest company, Teva Pharmaceutical Industries (TEVA.TA), but overall growth should stay strong. As such, Teva's announcement that it planned to slash its global workforce by a quarter, or 14,000 jobs -- 1,700 of those in Israel -- has caused concern, especially since ICL and Intel's exports have slipped in recent years.

  • Reuters13 hours ago

    Teva Pharm woes seen denting Israeli exports, economic growth

    Israel's export-dependent economy is expected to take a hit from planned job cuts and plant closures at its largest company, Teva Pharmaceutical Industries, but overall growth should stay strong. As such, Teva's announcement that it planned to slash its global workforce by a quarter, or 14,000 jobs -- 1,700 of those in Israel -- has caused concern, especially since ICL and Intel's exports have slipped in recent years.

  • Teva CEO to Meet Netanyahu With Blunt Message on Need for Cuts
    Bloombergyesterday

    Teva CEO to Meet Netanyahu With Blunt Message on Need for Cuts

    Teva Pharmaceutical Industries Ltd. Chief Executive Officer Kare Schultz will likely deliver a blunt message to Israeli Prime Minister Benjamin Netanyahu and his government in meetings this week: swallow ...

  • Reutersyesterday

    Strike over Teva Pharm job cuts briefly shuts down Israel

    Israel's main public-sector labour union staged a half-day strike on Sunday, closing the airport, stock exchange, banks and all government ministries to protest at mass layoffs planned by Teva Pharmaceutical Industries. Debt-ridden Teva, one of Israel's largest companies and the world's largest generics drugmaker, said last week it would cut its global workforce by more than a quarter, or 14,000 jobs. Some 1,700 jobs will be cut and a manufacturing site will be closed in Israel.

  • Reutersyesterday

    Strike over Teva Pharm job cuts briefly shuts down Israel

    Israel's main public-sector labour union staged a half-day strike on Sunday, closing the airport, stock exchange, banks and all government ministries to protest at mass layoffs planned by Teva Pharmaceutical Industries. Debt-ridden Teva, one of Israel's largest companies and the world's largest generics drugmaker, said last week it would cut its global workforce by more than a quarter, or 14,000 jobs. Some 1,700 jobs will be cut and a manufacturing site will be closed in Israel.

  • Israeli workers strike nationwide to protest Teva layoffs
    Associated Pressyesterday

    Israeli workers strike nationwide to protest Teva layoffs

    JERUSALEM (AP) — Israel's national trade union on Sunday held a half-day nationwide strike to protest generic drugmaker Teva's decision to lay off a quarter of its workforce, snarling traffic and shuttering key services across the country.

  • Strike Over Teva Firings Shuts Israel Bourse, Banks, Airport
    Bloomberg2 days ago

    Strike Over Teva Firings Shuts Israel Bourse, Banks, Airport

    Striking workers idled Israel’s international airport, government offices, banks and stock market for half a day, pressing to scale back Teva Pharmaceutical Industries Ltd.’s plan to fire 25 percent of ...

  • TheStreet.com3 days ago

    Teva Shares Rocket Higher Erasing Loses; CSX Savior Takes Leave -- ICYMI

    Here's what you need to know now for Friday, Dec. 15.

  • TheStreet.com3 days ago

    Teva Pharmaceutical 'Turned a Corner' This Week: Goldman Sachs

    The Petach Tikva, Israel-based drugmaker on Dec. 15 launched generic Viread a day after announcing plans to cut 14,000 jobs globally over the next two years as part of restructuring efforts. Here come ...

  • Can Teva Jump-Start Its Restructuring By Swiping Some Of Gilead's Sales?
    Investor's Business Daily3 days ago

    Can Teva Jump-Start Its Restructuring By Swiping Some Of Gilead's Sales?

    Teva continued its two-day upswing Friday after announcing the launch of a generic version of a drug from Gilead, a day after the drugmaker unveiled a massive cost-cutting plan.

  • SmarterAnalyst3 days ago

    Teva Pharmaceutical Industries Ltd (TEVA): Thanks for the Cuts But Where Is the Revenue Guidance?

    Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares have gained almost 15% in value since yesterday after new Danish CEO Kare Schultz's first conference call, where the recovering Israeli pharma giant's leadership unveiled cost cutting plans that outclassed Street-wide expectations. For Koffler, "the punch line" boils down to the giant's strategy to scale back $3 billion in expenses along with a reduction of a quarter of its workforce by 2019 from a projected cost base of $16.1 billion this year. The goal is for over half of this cost cutting, or past $1.5 billion, to be seen through next year.

  • Beware: Price Wars For Big Pharma, Biotech Companies On Horizon
    Investor's Business Daily3 days ago

    Beware: Price Wars For Big Pharma, Biotech Companies On Horizon

    The FDA could further pressure generic drugmakers in 2018 by continuing along its path of increased generic approvals.

  • Benzinga3 days ago

    Credit Suisse Upgrades Teva After Job Cuts Announced

    Impressed with the turnaround initiatives at Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA ), an analyst at Credit Suisse upgraded the company's  shares . The Analyst Credit Suisse analyst Vamil ...

  • Barrons.com3 days ago

    Teva or Neva: Will the Turnaround Plan Work?

    Shares of Teva Pharmaceuticals (TEVA) are higher on Friday, following a pair of upgrades. The moves come after Teva announced a restructuring plan on Thursday, following the stock's nearly 50% slump since the start of the year. Credit Suisse's Vamil Divan upgraded the stock to Neutral, writing that the company's turnaround looks positive and management is making the right moves--although execution is key.

  • Benzinga3 days ago

    Goldman Sachs: Now Is The Time To Get In On Teva's Turnaround

    Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA ) announced Thursday a plan to eliminate more than 25 percent of its worldwide workforce as part of a strategy to slash $3 billion of annual costs. ...

  • SmarterAnalyst3 days ago

    Teva Pharmaceutical Launches First Generic Formulation of Gilead’s Blockbuster Antiretroviral Truvada

    Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced this morning the exclusive US launch of Viread®1 (tenofovir disoproxil fumarate) tablets 300 mg, a generic version of Gilead Sciences' (NASDAQ:GILD) Viread tablets. Truvada was initially approved by FDA in 2004 to treat HIV in combination with other antiretroviral drugs, and later gained approval as the first drug to prevent sexually transmitted HIV-1 infection in uninfected adults in 2012. Viread®1 received an FDA approval for its Abbreviated New Drug Application (ANDA) in June, granting Teva the right to produce generic Truvada for the combination tablet’s use as a component of an HIV treatment regimen and as pre-exposure prophylaxis (PrEP).

  • MarketWatch3 days ago

    Teva to lay off 14,000 workers in bid for survival — but some are skeptical

    The restructuring is supposed to help turn around the beleaguered company, but could actually hurt it, some Wall Street analysts said.

  • MarketWatch3 days ago

    Teva to launch generic version of Gilead's Viread in the U.S.

    Shares of Teva Pharmaceutical Industries Ltd. rallied 3.5% in premarket trade Friday, after the drug maker announced the exclusive launch of generic Viread 1 tablets (300 milligrams) in the U.S. The rally ...

  • CNBC3 days ago

    Teva Pharmaceutical shares jump after Goldman upgrades embattled drugmaker, predicts turnaround

    Goldman Sachs raises its rating to buy for the generic drugmaker, citing Teva's aggressive cost-cutting targets for the next two years.